Programme at a glance

Programme at a glance, Barcelona

Thursday, 2 April 2020
01.00 - 23.59
WCO-IOF-ESCEO
19.00 - 20.40
WCO-IOF-ESCEO - OPENING CEREMONY
Chairpersons: John A. Kanis, Jean‑Yves Reginster
19.00
Best clinical papers published in 2019
René Rizzoli
19.45
ESCEO-IOF algorithm for the management of patients at low/high/very high risk of fracture
John A. Kanis
20.00
Opening of the meeting
Cyrus Cooper
20.20
Launch of the WHO package of tools on Integrated Care for Older People (ICOPE)
Islene Araujo de Carvalho (World Health Organization – Geneva)
20.25
Presentation of the 2020 ESCEO Medal of Excellence
Jean‑Yves Reginster
20.30
Presentation of the IOF Olof Johnell Science Award
Cyrus Cooper
20.35
Ten years of experience in fighting osteoporosis with the ESCEO-IOF Song powered by Johann Sebastian Bach
Christian Guenther
20.40 - 21.40
Welcome Cocktail Reception - Courtesy of the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the International Osteoporosis Foundation (IOF)
Friday, 3 April 2020
01.00 - 23.59
WCO-IOF-ESCEO
08.00 - 09.00
AVAILABLE INDUSTRY BREAKFAST SYMPOSIUM
08.00 - 09.00
NON-SPONSORED SYMPOSIA
Transgender therapy and relationship with bone disorders
Chairperson: Bruno Muzzi Camargos
Guidelines for hormonal therapy on transgender patients Ariana Sierra Osorio
From man to woman and from woman to man: Does it matter? Andres Coy
Densitometric acquisition, analysis and reporting Bruno Muzzi Camargos
Recommendations to maintain bone health on transgender patients Adriana Medina Orjuella
Vitamin D deficiency and rheumatic diseases
Chairperson: Panagiotis Athanassiou
Vitamin D deficiency and autoimmunity Ifigenia Kostoglou‑Athanassiou
Vitamin D deficiency and rheumatoid arthritis Yannis Dionyssiotis
Vitamin D deficiency and systemic lupus erythematosus Panagiotis Athanassiou
Vitamin D receptor polymorphisms and autoimmune diseases Lambros Athanassiou
Targeting bone and muscle: Novel therapeutic approaches to osteosarcopenia
Chairperson: Serge Ferrari
RANKL inhibition improves muscle strength and insulin sensitivity and restores bone mass from mice to humans Nicolas Bonnet
Old and new roles of amino acids and amino butyric acids in musculoskeletal diseases Marco Brotto
Fat as a therapeutic target in osteosarcopenia Gustavo Duque
Global Impact of Bone Health TeleECHO: The Prototype for Technology Enabled Collaborative Learning for Skeletal Healthcare
Chairperson: E. Michael Lewiecki
Introduction and Background of Bone Health TeleECHO E. Michael Lewiecki
National University of Ireland Galway Bone Health TeleECHO John J. Carey
Bone Health TeleECHO Moscow Zhanna Belaya
Rare Bone Disease TeleECHO Kassim Javaid
Panel discussion with all faculty
Nationwide identification of vertebral fragility fractures: Collaborating with Radiology
Chairperson: Bo Abrahamsen
Collaboration for better patient outcomes in vertebral fracture Jill Griffin
National audit on the reporting of incidentally found vertebral fractures in routine radiology practice Nadia Mahmood
Evaluation of the identification of vertebral fractures within fracture liaison services- looking to the future Kassim Javaid
Evaluating the demand on fracture liaison services with effective identification of vertebral fractures Helen Glenn
Winning the political case for change – launch of a policy toolkit for osteoporosis and fragility fractures
Chairperson: Ed Harding
Welcome and introduction to the project Ed Harding
Critical challenges in osteoporosis and fragility fracture care Cyrus Cooper
Policy actions needed to improve prevention and care of osteoporosis and fragility fractures John Bowis
Next steps for the network Ed Harding
Discussion and wrap-up Ed Harding
Joint Symposium of the IOF Skeletal Rare Diseases Working Group (SRD-WG) and the a European Reference Network on Rare Bone Diseases (ERN-BOND)
Chairperson: Maria Luisa Brandi
Diversity on the pathophysiology of increased bone fragility in rare bone diseases Naveen Hamdy
Quality of bone in Osteogenesis Imperfecta patients Luca Sangiorgi
Artificial Intelligence (AI) in Musculoskeletal Imaging – A Paradigm Shift ‘ante portas’?
Chairperson: Hans Peter Dimai
Principles of deep learning and machine learning John A. Carrino
AI in various modalities of musculoskeletal imaging (radiography, DXA, CT, MRT) Ronald M. Summers
Knee osteoarthritis assessment by AI increases physicians’ agreement rate and accuracy Stefan Nehrer
Managing fracture risk in primary care: roles and requirements
Chairperson: Zoe Paskins
Current challenges for primary care osteoporosis management Zoe Paskins
What osteoporosis care looks like in current UK general practice Elizabeth Cottrell
Primary care and the management of special groups at risk of fracture Elizabeth Cottrell
How primary care osteoporosis management can be improved John Edwards
Summing up: Challenges and opportunities for better integration of primary and secondary care Zoe Paskins
Close Zoe Paskins
08.00 - 09.00
Gut microbiota (GMB) and osteoarthritis (OA) management: outcomes of an ESCEO experts consensus meeting organized under the auspices of the World Health Organization Collaborating Center for Public Health Aspects of Musculoskeletal Health and Ageing.
Chairpersons: Islene Araujo de Carvalho, Sansin Tüzün, Francis Berenbaum
Introduction Emmanuel Biver
Gut microbiota and inflammation Claudio Franceschi
Role of gut microbiota in non-communicable disease and osteoarthritis management Emmanuel Biver
Discussion Francis Berenbaum
Panel: Islene Araujo de Carvalho, Francis Berenbaum, Emmanuel Biver, Maria Luisa Brandi, Philip Calder, Vincenzo Castronovo, Etienne Cavalier, Antonio Cherubini, Elaine M. Dennison, Claudio Franceschi, Nicholas R. Fuggle, Andrea Laslop, Pierre Miossec, Jean‑Yves Reginster, René Rizzoli, Thierry Thomas, Sansin Tüzün, Nicola Veronese
09.00 - 10.30
SCIENTIFIC SESSION I
Chairpersons: Cyrus Cooper, René Rizzoli
09.00
Plenary Lecture 1
Transient treatment discontinuation : pros and cons Michael R. McClung
09.30
Oral communication selected from abstracts
10.30 - 12.10
SCIENTIFIC SESSION II
Chairpersons: Jean‑Yves Reginster, John A. Kanis
10.30
Presentation of the ESCEO-IOF Herbert Fleisch Medal
René Rizzoli
10.35
Presentation of the IOF President's Award
Cyrus Cooper
10.40
Plenary Lecture 2
Differences in clinical guidelines Eugene McCloskey
11.10
Oral communication selected from abstracts
12.00
Presentation of the ESCEO-AgNovos Healthcare Young Investigator Awards
Jean‑Yves Reginster
14.00 - 15.00
Poster Viewing Session I
14.00 - 15.03
Oral presentation of selected posters
14.00 - 15.00
MEET-THE-EXPERT SESSIONS
Discussion of complex osteoporotic cases
Adolfo Diez‑Perez
Management of CKD-MBD
Jorge Cannata Andia
Nutritional approach of osteoporosis prevention
Stefania Maggi
GIOP : what to do ?
Emmanuel Biver
Pharmacoepidemiology of musculoskeletal disease
Daniel Prieto‑Alhambra
14.00 - 15.00
Alternative treatments for osteoarthritis: stem cells, platelet-rich plasma, autologous chondrocyte transplantation, ...: outcomes of an experts consensus meeting organized under the auspices of the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and under the auspices of the International Osteoporosis Foundation (IOF).
Chairpersons: Willem Lems, Francis Berenbaum
Introduction and scope of the problem Emmanuel Maheu
Role of surgical regenerative therapies in the management of knee osteoarthritis Richard Oreffo
Role of "alternative" treatments of knee osteoarthritis Nicholas R. Fuggle
Discussion Jean‑François Kaux
Panel: Francis Berenbaum, Jaime Branco, Maria Luisa Brandi, Olivier Bruyère, Philip Conaghan, Cyrus Cooper, Bernard Cortet, Maurizio Cutolo, Nicholas R. Fuggle, Germain Honvo, Jean‑François Kaux, Willem Lems, Emmanuel Maheu, Radmila Matijevic, Richard Oreffo, Andrew Price, Jean‑Yves Reginster, Roland Roth, Thierry Thomas, Nicola Veronese
14.00 - 15.00
Is there a role for MHT in the management of post-menopausal osteoporosis? Outcomes of an experts consensus meeting organized under the auspices of the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and under the auspices of the International Osteoporosis Foundation (IOF).
Chairpersons: Maria Luisa Brandi, Tim Hillard
Welcome and scope of the problem Antonio Cano
Effects of MHT on bone: What, when, how? Florence Trémollières
Risk/benefit ratio of MHT before and after 60 years Giuseppe Rosano
Discussion (Leader: Serge Rozenberg): All participants of the Working Group
Conclusions Antonio Cano
Panel: Mylène Aubertin‑Leheudre, Maria Luisa Brandi, Antonio Cano, Peter Collins, Cyrus Cooper, Andrea Genazzani, Nicholas Harvey, Tim Hillard, John A. Kanis, Jean‑Marc Kaufman, Irene Lambrinoudaki, Andrea Laslop, Daniel Prieto‑Alhambra, Jean‑Yves Reginster, René Rizzoli, Giuseppe Rosano, Serge Rozenberg, Florence Trémollières
15.00 - 17.00
SCIENTIFIC SESSION III
Chairpersons: Nicholas Harvey, Bess Dawson‑Hughes
15.00
Plenary Lecture 3
Bone turnover markers in clinical practice Etienne Cavalier
15.30
Oral communication selected from abstracts
16.30
Plenary Lecture 4
Bone fragility: beyond bone loss Serge Ferrari
15.00 - 16.45
COMMITTEE OF NATIONAL SOCIETIES SPECIAL PLENARY SESSION
‣ Musculoskeletal diseases: diagnosis, management and consequences
Chairpersons: Philippe Halbout, Jean‑Yves Reginster, Famida Jiwa
15.45
Presentation of the IOF Committee of National Societies Medal
Jean‑Yves Reginster
Saturday, 4 April 2020
01.00 - 23.59
WCO-IOF-ESCEO
08.00 - 09.00
NON-SPONSORED SYMPOSIA
Inter-relation between bone, muscle, strength and fat in older adults: influence of nutrition and exercise
Chairperson: Mylène Aubertin‑Leheudre
Influence of initial protein intake on bone density and architecture in dynapenic-obese older adults Fanny Buckinx
Preserving Body & muscle composition in Obese-Osteopenic Older Women: High-Intensity Interval Training a potential intervention? Mylène Aubertin‑Leheudre
Physical performance in obese-osteopenic elderly women: high-intensity interval training more efficient than continuous aerobic training? Bertrand Fougère
Bone Health in Patients with Chronic Kidney Disease
Chairperson: Maria Coco
Role of zinc in osteoporosis and vascular calcification: killing 2 birds with 1 stone? Wei Chen
Bone, skeletal muscle, and sarcopenia in chronic kidney disease Matthew Abramowitz
Treating Bone Disease in the Woman with Chronic Kidney Disease Maria Coco
Stronger Together: Innovative Collaborative Initiatives to Improve Osteoporosis Care The Asia Pacific Consortium on Osteoporosis and the Asia Pacific Fragility Fracture Alliance
Chairperson: John A. Kanis
The Burden of Osteoporosis and Fragility Fractures in Asia Pacific Joon‑Kiong Lee
Asia Pacific Consortium on Osteoporosis: Development of The Framework Manju Chandran
Asia Pacific Fragility Fracture Alliance: Working group outputs Derrick Chan
Q&A Session
The importance of explanations: improving communication about osteoporosis and osteoarthritis to support uptake of evidence-based treatments
Chairperson: John Edwards
Evidence-care gap in osteoporosis and osteoarthritis John Edwards
What do we already know about how to frame explanations? Zoe Paskins
Targeting communication in the clinician-patient consultation to improve uptake of fracture prevention treatments: early findings from the iFraP study Zoe Paskins
What patients with osteoarthritis want and need to know to support them to undertake self-management: early findings from the PEP-OA study Elizabeth Cottrell
Lessons for clinical practice and research John Edwards
Close John Edwards
Patient-reported outcomes in sarcopenia
Chairpersons: Yves Rolland, Olivier Bruyère
Welcome and introduction Olivier Bruyère
Quality of life in sarcopenia : an update Charlotte Beaudart
Overview of generic and specific Patient Reported Outcome Measures (PROMs) in sarcopenia Anton Geerinck
Conclusion Yves Rolland
Questions
CTF getting to gold framework
Chairperson: Kassim Javaid
Presentation of the Getting to Gold programme framework and milestones Kassim Javaid
Evaluation of the mentorship programme Monica Calo
Evaluation of the mentorship programme- mentees perspective Andrea Olascoaga
Next steps for Getting to Gold Kassim Javaid
08.00 - 09.00
AVAILABLE INDUSTRY BREAKFAST SYMPOSIUM
08.00 - 09.00
AVAILABLE INDUSTRY BREAKFAST SYMPOSIUM
08.00 - 09.00
Radiofrequency Echographic Multi-Spectrometry for the in-Vivo Assessment of Bone Strength: State of the Art: outcomes of an experts consensus meeting organized under the auspices of the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and under the auspices of the International Osteoporosis Foundation (IOF).
Chairpersons: Maria Luisa Brandi, Adolfo Diez‑Perez
Introduction Hans Peter Dimai
Current role of bone strength in the assessment of fracture risk Thierry Thomas
Radiofrequency echographic multi-spectrometry: Basic principles and clinical validation Maria Luisa Brandi
Discussion Stefano Gonnelli
Panel: Jaime Branco, Maria Luisa Brandi, Olivier Bruyère, Sergio Casciaro, Loredana Cavalli, Bernard Cortet, Adolfo Diez‑Perez, Hans Peter Dimai, Stefano Gonnelli, Philippe Halbout, John A. Kanis, Jean‑Marc Kaufman, Médéa Locquet, Radmila Matijevic, Jean‑Yves Reginster, René Rizzoli, Thierry Thomas
08.00 - 09.00
Impact of whole dairy matrix on musculoskeletal health and aging. Outcomes of a workshop organized under the auspices of the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO).
Chairperson: Arne Astrup
Introduction Arne Astrup
The concept of food matrix compared to single nutrients Ian Givens
Importance of dairy matrix for skeletal health Sandra Iuliano
Discussion Yannis Manios
Conclusion and wrap up Arne Astrup
Panel: Arne Astrup, Nina Geiker, Ian Givens, Sandra Iuliano, Jean‑Michel Lecerf, Yannis Manios, Christian Molgaard, Jean‑Yves Reginster, René Rizzoli, Luc J. C. van Loon
08.00 - 09.00
EUGMS-ESCEO-IOF Joint Session "Avoiding medication related harm when treating osteoarticular disease in older people"
Chairperson: Finbarr Martin
Introduction: Medication related harm Finbarr Martin
Drugs that may harm your older patients: potentially inappropriate prescribing Mirko Petrovic
Potential problems in the use of drugs for osteoarticular conditions in old age Antonio Cherubini
09.00 - 10.30
SCIENTIFIC SESSION IV
Chairpersons: Elaine M. Dennison, Olivier Bruyère
09.00
Plenary Lecture 5
Sarcopenia : new definitions and clinical implications Alfonso Cruz Jentoft
09.30
Oral communication selected from abstracts
10.20
Presentation of the ESCEO-IOF Pierre Meunier Young Scientist Award
John A. Kanis
10.30 - 12.10
SCIENTIFIC SESSION V
Chairpersons: Adolfo Diez‑Perez, Manju Chandran
10.30
Presentation of the IOF Medal of Achievement
Nicholas Harvey
10.40
Plenary Lecture 6
How to reduce falls in oldest people ? Heike A. Bischoff‑Ferrari
11.10
Oral communication selected from abstracts
14.00 - 15.00
Poster Viewing Session II
14.00 - 15.03
Oral presentation of selected posters
14.00 - 15.00
MEET-THE-EXPERT SESSIONS
Menopausal hormone therapy in 2020
Santiago Palacios
Risks and benefits of calcium supplementation
Nicholas Harvey
Physical therapy for osteoarthritis
Olivier Bruyère, Daniel Pinto
Local bone treatments
Maria Luisa Brandi
Milk, yogurt, cheese and bone: Friends or foes ?
Sandra Iuliano
Structural determinants and purity differ in food supplement respect to CS based pharma products: effect on biological features (supported by an Unrestricted Educational Grant from Ibsa)
Chiara Schiraldi
14.00 - 15.00
Algorithm for the use of biochemical markers of bone turnover in the diagnosis and follow-up of treatment for osteoporosis: outcomes of an ESCEO experts consensus meeting organized under the auspices of the World Health Organization Collaborating Center for Public Health Aspects of Musculoskeletal Health and Ageing
Chairpersons: Etienne Cavalier, Adolfo Diez‑Perez
Introduction John A. Kanis
Clinical application of bone turnover markers in post-menopausal osteoporosis Mattias Lorentzon
Algorithm for the assessment of anti-osteoporosis treatments by bone turnover markers Eugene McCloskey
Discussion Markus Herrmann
Panel: Jaime Branco, Maria Luisa Brandi, Olivier Bruyère, Etienne Cavalier, Roland D. Chapurlat, Cyrus Cooper, Bernard Cortet, Adolfo Diez‑Perez, Serge Ferrari, Andrea Ildiko Gasparik, Markus Herrmann, Niklas Rye Jorgensen, John A. Kanis, Jean‑Marc Kaufman, Andrea Laslop, Médéa Locquet, Mattias Lorentzon, Radmila Matijevic, Eugene McCloskey, Salvatore Minisola, Richard Pikner, Jean‑Yves Reginster, René Rizzoli, Pawel Szulc
15.00 - 17.00
SCIENTIFIC SESSION VI
Chairpersons: Charlotte Beaudart, E. M. Curtis
15.00
Plenary Lecture 7
What did we learn from the recent large vitamin D trials Bess Dawson‑Hughes
15.30
Oral communication selected from abstracts
16.30
Plenary Lecture 8
New pharmacological treatments for osteoarthritis Elaine M. Dennison
15.00 - 16.45
Committee of Scientific Advisors Special Session: Technology, comorbidity and rehabilitation in bone health- highlights from the IOF Committee of Scientific Advisors 2020
Chairpersons: Nicholas Harvey, Serge Ferrari
Novel technologies for the non-invasive evaluation of femoral strength in fracture risk assessment Mary Bouxsein
Optimisation of bone health in chronic kidney disease: EUROD-IOF consensus statement Kassim Javaid
Maximising function through post-fracture rehabilitation Olivier Bruyère
17.00 - 18.30
AVAILABLE INDUSTRY SATELLITE SYMPOSIUM
Sunday, 5 April 2020
01.00 - 23.59
WCO-IOF-ESCEO
08.00 - 09.00
NON-SPONSORED SYMPOSIA
Fragility fractures in Sub-Saharan Africa: Time to break the myth!
Chairperson: Celia L. Gregson
Chairs introduction and setting the scene Celia L. Gregson
Trends in fracture incidence in high-income countries Bo Abrahamsen
Breaking the myth in Sub-Saharan Africa – what do we know about fragility fracture? Kate Ward
Panel discussion
Summary and wrap-up Celia L. Gregson
DENOSUMAB discontinuation: Trends, challenges, ups-and-downs
Chairperson: Bruno Muzzi Camargos
Vertebral Fracture Following D-Mab Discontinuation: Supporting Data Oscar Rosero Olarte
Pathophysiology Of The Osteoclastic “Flare” After Discontinuation Adriana Medina Orjuella
Biochemichal And Imaging Assessment: Ups And Downs Bruno Muzzi Camargos
Bone Loss After D-Mab Discontinuation In 150 Patients Maria Belen Zanchetta
D-Mab Patient Management In The Clinical Setting: Stepping On The Right Foot Luis Fernando Vidal Neira
When a DXA is indicated, a VFA is also recommended
Chairpersons: Willem Lems, Kristina Åkesson
Introduction Willem Lems
Clinical relevance of vertebral fractures Julien Paccou
Radiological diagnosis of vertebral fractures with VFA Jean Zhang
Advantages and limitations of VFA Manju Chandran
Discussion Kristina Åkesson
Behavioral strategies for the busy clinician
Chairperson: Daniel Pinto
Go With The flow: Remembering Your Patients Are Human Julie Miller
Using A Brief Motivational Interviewing Approach in Rheumatology Practice Steven Cole
The Development of Electronic Brief Action Planning Daniel Pinto
Female Bone Health: a gynecological approach on women's special conditions
Chairperson: Adriana Orcesi Pedro
Opening Adriana Orcesi Pedro
Update on management of low bone mass in young women Adriana Orcesi Pedro
Bone mass and fracture risk during pregnancy and lactation Ben‑Hur Albergaria
Evaluation and management of osteopenia and osteoporosis in breast and gynecological cancer survivors Marcelo Luis Steiner
Question & Answers with audience
Sarcopenic obesity
Chairperson: Ifigenia Kostoglou‑Athanassiou
Sarcopenia. Diagnosis and evaluation Panagiotis Athanassiou
Sarcopenia and nutrition Lambros Athanassiou
Sarcopenic obesity. Definition and pathophysiology Ifigenia Kostoglou‑Athanassiou
Sarcopenic obesity. Management Yannis Dionyssiottis
Discussion
The Brussels study on the early predictors of frailty (BUTTERFLY) – part 1: Defining Frailty
Chairperson: Dominique Verté
Introduction Ivan Bautmans
Towards a uniform language of Frailty Roberta Vella‑Azzopardi
Fatigue in the frailty constructs Veerle Knoop
The disability paradox in the frailty constructs Axelle Costenoble
Measures of cognition in the frailty constructs Mirko Petrovic
Discussion
08.00 - 09.00
AVAILABLE INDUSTRY BREAKFAST SYMPOSIUM
08.00 - 09.00
ESPRM-ESCEO-IOF Joint Session
Fibromyalgia : An evidence-based approach for diagnosis and management
Chairperson: Fitnat Dincer
Update in Diagnosis of Fibromyalgia on the basis of Evidence Based Medicine Andreas Winkelman
Update in Pharmacological Management of Fibromyalgia on the Basis of Evidence Based Medicine Fitnat Dincer
Update in Non-Pharmacological Management of Fibromyalgia on the Basis of Evidence Based Medicine Raquel Valero, Susana Munoz
08.00 - 09.00
Educational Lecture
‣ Management of hyperparathyroidism in chronic kidney disease
Pierre Delanaye
08.00 - 09.00
SICOT-ESCEO-IOF Symposium: Fracture Liaison Services (FLS) in Orthopaedic Surgery
Chairpersons: Josée Delisle, Philippe Halbout
Opening message Philippe Halbout, Josée Delisle
Success story of collaboration between orthopaedics and rest of the world in FLS! How can I work with my orthopaedic surgeon? Julio Fernandes
Getting FLSs sustainable - key steps Kassim Javaid
Teams and empowerment! How to create synergy between the Nurse, Doctor, Family and the Patient? Josée Delisle
Crossfire and Q&A
Closing message Josée Delisle
08.00 - 09.00
Assessment of cardio-vascular safety of anti-osteoporosis medications. Outcomes of an experts consensus meeting organized under the auspices of the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and under the auspices of the International Osteoporosis Foundation (IOF).
Chairpersons: Adolfo Diez‑Perez, Nicholas R. Fuggle
Welcome and scope of the problem Adolfo Diez‑Perez
Assessment of cardio-vascular safety of Calcium and Vitamin D Nicholas Harvey
Assessment of cardio-vascular safety of menopausal hormonal therapy and SERMs Santiago Palacios
Assessment of cardio-vascular safety of peptides and monoclonal antibodies used as a treatment for osteoporosis René Rizzoli
Discussion (Leader: Santiago Palacios): All participants of the Working Group
Conclusions Nicholas R. Fuggle
Panel: Maria Luisa Brandi, Antonio Cano, Cyrus Cooper, Elaine M. Dennison, Adolfo Diez‑Perez, Nicholas R. Fuggle, Nicholas Harvey, John A. Kanis, Jean‑Marc Kaufman, Santiago Palacios, Daniel Prieto‑Alhambra, Jean‑Yves Reginster, René Rizzoli, Serge Rozenberg, Thierry Thomas, Florence Trémollières
09.00 - 10.00
Poster Viewing Session III
09.00 - 10.00
MEET-THE-EXPERT SESSIONS
Bone and joints in intense competition sport : lesson for the practice ?
Jean‑François Kaux
Bariatric surgery, bone and joints
Daniel Prieto‑Alhambra
Androgens, bone and muscles
Jean‑Marc Kaufman
Efficacy and cost/benefit of FLS
Radmila Matijevic
High Bone Mass: What are the causes and how should we manage it?
Celia L. Gregson
Local Bone Treatment in Osteoporosis (supported by an Unrestricted Educational Grant from Agnovos Healthcare)
Andreas Kurth
10.00 - 12.00
SCIENTIFIC SESSION VII
Chairpersons: Famida Jiwa, Serge Ferrari
10.00
Plenary Lecture 9
Rare bone diseases : what do they teach us for musculoskeletal disorders management Kassim Javaid
10.30
Presentation of the ESCEO-IOF Young Investigator Awards
Cyrus Cooper
10.40
Oral communication selected from abstracts
11.30
Plenary Lecture 10
Strategies to fill the Treatment Gap in Osteoporosis: place of Combination and Sequential Regimens Manju Chandran
12.00 - 13.00
NON-SPONSORED SYMPOSIA
Osteosarcopenia school
Chairpersons: Mark Lissens, Yannis Dionyssiotis
Osteosarcopenia Ifigenia Kostoglou‑Athanassiou
Neurogenic osteoporosis due to sarcopenia in post poliomyelitis patients Mark Lissens
Osteosarcopenia school Yannis Dionyssiotis
Discussion
Clinical diagnostics of chronic and acute pain. Multimodal approach
Chairperson: Olga Kurushina
Acute and chronic pain: The difference between diagnostic approaches Olga Kurushina
Pain and biomechanics Alexander Barulin
Features of clinical diagnosis of cervicogenic headache Anna Drushlyakova
Diagnosis of temporomandibular disorders in patients with chronic facial pain Bogdan Kalinchenko
Awareness, Risk factors and Early Detection of Osteoporosis in Turkish Postmenopausal Female Patients
Chairpersons: Pinar Borman, Vesile Sepici
The Awareness and Knowledge of Osteoporosis and Risk factors in a group Turkish Geriatric Patients Belgin Karaoglan
The Knowledge about Osteoporosis in a Group of Turkish Females: Relationship with Quantitative Ultrasonographic Scores Pinar Borman
Laboratory overview of bone turnover markers Aylin Sepici Dincel
Risk Factors of osteoporosis and osteoporotic fractures Vesile Sepici
Controversies regarding the management of gout and asymptomatic hyperuricemia
Chairperson: Razvan Adrian Ionescu
Uric acid - Friend or foe? Mihai Bojinca
Asymptomatic hyperuricemia - The hidden realm (Imaging clue) Florentin Ananu Vreju
Bone mineral density in hyperuricemia and gout - Collateral damage? Claudiu Avram
Gout treatment - As easy as it seems? Razvan Adrian Ionescu
The microcirculation abnormalities in osteoporosis and osteoarthritis
Chairpersons: Sekib Sokolovic, Alena Rudenko
Introduction Sekib Sokolovic
Angiogenesis and Bone Gerold Holzer
Vascular pathology and Osteoarthritis, Imaging of Microcirculation Juan Jose Scali
The Microcirculation abnormalities in Osteoporosis and Osteoarthritis Sekib Sokolovic
Discusion and Closing remarks
Non-pharmacological approaches in the management of osteoporosis
Chairperson: Yesim Gokce Kutsal
How to modify life-style? Yesim Gokce Kutsal
The role of exercises: What type of exercise when? Jale Meray
Are orthoses and physical modalities effective for osteoporosis and/or osteoporotic fractures? Ayse A. Kucukdeveci
Case presentations Yesim Kirazli
Relevance of body composition in chronic diseases
Chairperson: Mislav Radić
Association of body composition with disease activity in rheumatoid arthritis Mislav Radić
Relationship of body composition with osteoporosis Tonko Vlak
Impact of disability on body composition in multiple sclerosis Ozren Polasek
The Brussels study on the early predictors of frailty (BUTTERFLY) – part 2: First results from the BUTTERFLY study
Chairperson: Dominique Verté
Introduction Ivan Bautmans
General profile of the Butterfly participants Aziz Debain
Validated equations for estimating body composition in the oldest old Jona Van den Broeck
Immunosenescence signatures in pre-frailty Rose Njemini
Discussion